Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Nutritional state-dependent changes in subcortical limbic structures in anorexia nervosa are linked to leptin, ghrelin, and neurofilament light
    Published on 2026-05-21
    2 months ago
  • Resting-state functional connectivity of the default mode network as a predictor for escitalopram response in adolescents with depression
    Published on 2026-05-21
    2 months ago
  • Adjunctive D-cycloserine to intermittent theta-burst transcranial magnetic stimulation in fibromyalgia: a randomized placebo-controlled trial
    Published on 2026-05-20
    2 months ago
  • Carprofen and buprenorphine delivery using micropipette-guided drug administration (MDA) in mice
    Published on 2026-05-20
    2 months ago
  • An opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol
    Published on 2026-05-20
    2 months ago
  • Good vibrations: Sternal vibration enhances white matter density and interoceptive awareness
    Published on 2026-05-16
    2 months ago
  • Simvastatin rescues cognitive impairment in an Aβ1-42-induced model of Alzheimer’s disease through the HDAC2-BDNF signaling pathway
    Published on 2026-05-15
    2 months ago
« Previous 1 … 8 9 10 11 12 … 143 Next »
Journal of Psychopharmacology
  • Pharmacological characterization of 4-F-3-Me-α-PVP: A novel synthetic cathinone with psychostimulant effects and abuse liability in rodents
    Published on 2026-03-14
    5 months ago
  • A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder
    Published on 2026-03-14
    5 months ago
  • Enhancement of memory network activity in schizophrenia patients by phosphodiesterase-4 (PDE4) inhibitor, roflumilast: A pilot study
    Published on 2026-03-11
    5 months ago
  • The effects of transcranial direct current stimulation (tDCS) on subjective, autonomic and neuropsychological response in the 7.5% CO2 experimental model of anxiety
    Published on 2026-03-11
    5 months ago
  • Effects of ayahuasca on neuropsychological performance and social cognition: A systematic review
    Published on 2026-03-09
    5 months ago
  • Precision dosing of clozapine: A physiologically based pharmacokinetic/pharmacodynamic model integrating genetic polymorphisms and clinical outcomes
    Published on 2026-03-09
    5 months ago
  • Confronting mortality: A meta-analysis and systematic review of psychedelic experiences and death anxiety
    Published on 2026-03-09
    5 months ago
« Previous 1 … 8 9 10 11 12 … 150 Next »
European Neuropsychopharmacology
  • Critical considerations on the trial of FAAH inhibitor JNJ-42165279 in major depressive disorder with anxious distress
    Published on 2026-02-28
    5 months ago
  • Unraveling the genetic architecture of depression-atherosclerosis comorbidity: a paradigm shift in understanding mind-heart connections
    Published on 2026-02-27
    5 months ago
  • Methodological points for consideration: Enhancing the interpretation of the COH-FIT findings
    Published on 2026-02-27
    5 months ago
  • Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study
    Published on 2026-02-27
    5 months ago
  • Polygenic risk scores reveal genetic underpinnings of comorbidity betweensubstance use disorders and ADHD
    Published on 2026-02-27
    5 months ago
  • The antioxidant paradox in pregnancy
    Published on 2026-02-27
    5 months ago
  • Complexity or simplicity? A replication analysis of low heart rate as a predictor of TMS response in major depressive disorder
    Published on 2026-02-20
    5 months ago
« Previous 1 … 8 9 10 11 12 … 168 Next »

   Pharma Pub